妊娠期高血压、子痫前期和子痫与未来神经障碍
这项基于瑞典医学出生登记处的队列研究纳入648385名初产妇,评估妊娠期高血压、子痫前期和子痫与产后新发偏头痛、头痛、癫痫、睡眠障碍或精神疲劳的关联。结果显示三种妊娠并发症均与复合神经结局风险升高相关,子痫与癫痫风险升高超过5倍相关。作者认为产后随访时应关注持续性或新发的神经系统症状。
要点
- 妊娠期高血压、子痫前期和子痫均与产后新发神经障碍复合结局风险升高相关。
- 子痫与癫痫风险升高超过5倍相关(aHR 5.31,95%CI 2.85-9.89)。
- 作者建议产后随访时关注持续性或新发的神经系统症状。
核心结论
- 妊娠期高血压、子痫前期和子痫与产后数月到数年内新发偏头痛、头痛、癫痫、睡眠障碍或精神疲劳的风险升高相关。
研究设计与样本
- 基于登记的队列研究, exposures取自2005至2018年瑞典医学出生登记处,随访使用国家患者登记处,从分娩后42天开始至首次事件、死亡、移民或随访期结束(2019年)。
- 共识别659188名2005至2018年间单胎妊娠初产妇,排除慢性高血压(n=4271)或孕前神经障碍(n=6532)后,最终研究人群为648385名女性,首次妊娠时平均年龄28.5(SD 5.0)岁。
- 风险采用Cox回归分析计算,以调整后风险比(aHR)及95%CI表示;数据分析于2023年进行。
主要发现
- 与血压正常妊娠的女性相比,妊娠期高血压(n=11133)与复合神经结局风险升高相关(aHR 1.27,95%CI 1.12-1.45)。
- 子痫前期(n=26797)与复合神经结局风险升高相关(aHR 1.32,95%CI 1.22-1.42)。
- 子痫(n=625)与复合神经结局风险升高相关(aHR 1.70,95%CI 1.16-2.50)。
- 子痫与癫痫风险升高超过5倍相关(aHR 5.31,95%CI 2.85-9.89)。
关键数值与推荐
- 主要结局为偏头痛、头痛、癫痫、睡眠障碍或精神疲劳的复合神经结局。
- 暴露为妊娠期高血压、子痫前期和子痫。
- 随访从分娩后42天开始,至首次事件、死亡、移民或2019年随访期结束。
临床怎么用
- 指南推荐对妊娠期高血压和子痫前期女性产后随访,因其心血管疾病风险增加。
- 作者认为在这些随访中,照护者还应关注持续性或新发的神经系统症状,因为该组女性似乎易发生或经历神经障碍。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Gestational hypertension, preeclampsia, and eclampsia are established risk factors for stroke and dementia later in life. Whether these pregnancy complications are associated with an increased risk of new-onset neurological disorders within months to years after giving birth is not known. OBJECTIVE: To explore whether gestational hypertension, preeclampsia, and eclampsia are associated with new-onset migraine, headache, epilepsy, sleep disorder, or mental fatigue within months to years after giving birth. DESIGN, SETTING, AND PARTICIPANTS: In this register-based cohort study, exposures were identified in the Swedish Medical Birth Register from 2005 to 2018. Follow-up was conducted using the National Patient Register, containing diagnoses from specialized inpatient and outpatient care. Follow-up started 42 days after delivery and continued until the first event, death, emigration, or the end of the follow-up period (2019). The risk was calculated with Cox regression analysis and expressed as adjusted hazard ratio (aHR) with a 95% CI. Through the Swedish Medical Birth Register, 659 188 primiparous women with singleton pregnancies between 2005 and 2018 were identified. Women with a diagnosis of chronic hypertension (n = 4271) or a prepregnancy neurological disorder (n = 6532) were excluded. The final study population included 648 385 women. Data analyses were conducted in 2023. EXPOSURES: Gestational hypertension, preeclampsia, and eclampsia. MAIN OUTCOME: The primary outcome was a composite neurological outcome of migraine, headache, epilepsy, sleep disorder, or mental fatigue. RESULTS: The study included 648 385 women with a mean age of 28.5 (SD, 5.0) years at the time of their first pregnancy. Women with gestational hypertension (n = 11 133), preeclampsia (n = 26 797), and eclampsia (n = 625) all had an association with increased risk for a new-onset neurological disorder compared with women with normotensive pregnancies. The aHR for gestational hypertension was 1.27 (95% CI, 1.12-1.45), 1.32 (95% CI, 1.22-1.42) for preeclampsia, and 1.70 (95% CI, 1.16-2.50) for eclampsia. When exploring individual outcomes, women with eclampsia were associated with more than a 5 times increased risk of epilepsy (aHR, 5.31; 95% CI, 2.85-9.89). CONCLUSION AND RELEVANCE: In this study, gestational hypertension, preeclampsia, and eclampsia were associated with an increased risk of new-onset migraine, headache, epilepsy, sleep disorder, or mental fatigue within months to years after giving birth. Guidelines recommend follow-up after delivery for women with gestational hypertension and preeclampsia for their increased risk of cardiovascular disease. At these visits, caregivers should also pay attention to persisting or new-onset of neurological symptoms, since this group of women appears to be vulnerable to developing or experiencing neurological disorders.
引用
- Friis T, Bergman L, Hesselman S, et al. Gestational Hypertension, Preeclampsia, and Eclampsia and Future Neurological Disorders. JAMA Neurol. 2025. PMID: 39714850. doi:10.1001/jamaneurol.2024.4426
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。